Gene Symbol | Gene ID | Gene Info |
---|---|---|
ONECUT1
|
ENSG00000169856.7 | one cut homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_53083087_53083325 | ONECUT1 | 997 | 0.674101 | 0.49 | 1.8e-01 | Click! |
chr15_53082686_53082942 | ONECUT1 | 605 | 0.827224 | 0.46 | 2.1e-01 | Click! |
chr15_53150755_53150906 | ONECUT1 | 68621 | 0.130662 | 0.43 | 2.5e-01 | Click! |
chr15_53072962_53073193 | ONECUT1 | 303 | 0.937021 | 0.37 | 3.2e-01 | Click! |
chr15_53150010_53150161 | ONECUT1 | 67876 | 0.132197 | -0.37 | 3.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_136478308_136478499 | 2.49 |
KHDRBS3 |
KH domain containing, RNA binding, signal transduction associated 3 |
7453 |
0.25 |
chrX_122317435_122317817 | 1.89 |
GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
380 |
0.93 |
chr13_38443188_38443573 | 1.57 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
480 |
0.86 |
chr10_15126072_15126273 | 1.43 |
ACBD7 |
acyl-CoA binding domain containing 7 |
4603 |
0.18 |
chr10_124254663_124255115 | 1.22 |
HTRA1 |
HtrA serine peptidase 1 |
11318 |
0.2 |
chr16_86602524_86602840 | 1.20 |
RP11-463O9.5 |
|
1315 |
0.34 |
chr11_121968787_121969071 | 1.17 |
ENSG00000207971 |
. |
1623 |
0.3 |
chr7_20372086_20372237 | 1.17 |
CTA-293F17.1 |
|
791 |
0.56 |
chr7_134465998_134466492 | 1.09 |
CALD1 |
caldesmon 1 |
1816 |
0.49 |
chr15_49715834_49715985 | 1.08 |
FGF7 |
fibroblast growth factor 7 |
452 |
0.86 |
chr16_65154176_65154454 | 0.96 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1518 |
0.59 |
chr6_141884450_141884959 | 0.93 |
ENSG00000222764 |
. |
77155 |
0.13 |
chr5_102202832_102203172 | 0.93 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
1182 |
0.66 |
chr5_16934155_16934306 | 0.91 |
MYO10 |
myosin X |
1817 |
0.38 |
chr2_164590053_164590372 | 0.91 |
FIGN |
fidgetin |
2305 |
0.48 |
chr15_63338014_63338217 | 0.90 |
TPM1 |
tropomyosin 1 (alpha) |
2140 |
0.28 |
chr6_132691040_132691268 | 0.90 |
MOXD1 |
monooxygenase, DBH-like 1 |
5050 |
0.31 |
chr7_55086865_55087042 | 0.89 |
EGFR |
epidermal growth factor receptor |
142 |
0.98 |
chr2_217557124_217557955 | 0.89 |
AC007563.5 |
|
1648 |
0.3 |
chr3_44063258_44064101 | 0.88 |
ENSG00000252980 |
. |
48900 |
0.17 |
chr1_200385404_200385587 | 0.87 |
ZNF281 |
zinc finger protein 281 |
6311 |
0.32 |
chr7_120632120_120632293 | 0.86 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
2530 |
0.29 |
chr15_59663421_59663716 | 0.85 |
FAM81A |
family with sequence similarity 81, member A |
1324 |
0.28 |
chr18_25703623_25703892 | 0.85 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
26564 |
0.27 |
chr18_20290957_20291198 | 0.85 |
RP11-370A5.1 |
|
20451 |
0.22 |
chr11_120208718_120208869 | 0.84 |
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
847 |
0.6 |
chr4_114897087_114897254 | 0.84 |
ARSJ |
arylsulfatase family, member J |
2982 |
0.35 |
chr5_34658039_34658190 | 0.84 |
CTD-2024P10.1 |
|
759 |
0.56 |
chr1_203445001_203445152 | 0.83 |
PRELP |
proline/arginine-rich end leucine-rich repeat protein |
120 |
0.97 |
chr10_119303944_119304573 | 0.83 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
321 |
0.88 |
chr21_32715523_32716836 | 0.82 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr3_86987673_86987824 | 0.82 |
VGLL3 |
vestigial like 3 (Drosophila) |
52104 |
0.19 |
chr1_82267993_82268232 | 0.82 |
LPHN2 |
latrophilin 2 |
2030 |
0.49 |
chr21_30631051_30631499 | 0.81 |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
39917 |
0.13 |
chr6_39761310_39761623 | 0.80 |
DAAM2 |
dishevelled associated activator of morphogenesis 2 |
672 |
0.79 |
chr11_69454506_69454752 | 0.80 |
CCND1 |
cyclin D1 |
1226 |
0.52 |
chr12_105477204_105477480 | 0.80 |
ALDH1L2 |
aldehyde dehydrogenase 1 family, member L2 |
999 |
0.49 |
chr21_17960305_17960805 | 0.80 |
ENSG00000207863 |
. |
2002 |
0.4 |
chr2_175743189_175743666 | 0.78 |
CHN1 |
chimerin 1 |
30948 |
0.19 |
chr1_147520658_147521465 | 0.78 |
ENSG00000206585 |
. |
9894 |
0.21 |
chr16_73090314_73090763 | 0.77 |
ZFHX3 |
zinc finger homeobox 3 |
3059 |
0.3 |
chr12_3069053_3070004 | 0.77 |
TEAD4 |
TEA domain family member 4 |
445 |
0.77 |
chr15_96865528_96865838 | 0.77 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
191 |
0.93 |
chr17_15166292_15166618 | 0.77 |
PMP22 |
peripheral myelin protein 22 |
549 |
0.68 |
chr3_173302379_173302636 | 0.76 |
NLGN1 |
neuroligin 1 |
162 |
0.98 |
chr1_57041274_57041425 | 0.76 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
3892 |
0.33 |
chr3_25471508_25471659 | 0.76 |
RARB |
retinoic acid receptor, beta |
1781 |
0.47 |
chr7_42233622_42233818 | 0.76 |
GLI3 |
GLI family zinc finger 3 |
33600 |
0.25 |
chr14_33404486_33404689 | 0.76 |
NPAS3 |
neuronal PAS domain protein 3 |
448 |
0.91 |
chr1_98675794_98676024 | 0.75 |
ENSG00000221777 |
. |
163032 |
0.04 |
chr1_244437416_244437658 | 0.74 |
C1orf100 |
chromosome 1 open reading frame 100 |
78400 |
0.1 |
chr2_164592268_164592669 | 0.73 |
FIGN |
fidgetin |
49 |
0.99 |
chr15_96903910_96904291 | 0.73 |
AC087477.1 |
Uncharacterized protein |
387 |
0.85 |
chr16_14280583_14281066 | 0.72 |
MKL2 |
MKL/myocardin-like 2 |
52 |
0.98 |
chr16_67634950_67635107 | 0.71 |
AC009095.4 |
|
14217 |
0.09 |
chr8_131918688_131918877 | 0.70 |
RP11-737F9.2 |
|
13751 |
0.24 |
chr7_45961953_45962825 | 0.70 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
916 |
0.6 |
chr1_149908805_149909071 | 0.70 |
MTMR11 |
myotubularin related protein 11 |
147 |
0.91 |
chr11_86085513_86085741 | 0.69 |
CCDC81 |
coiled-coil domain containing 81 |
151 |
0.96 |
chr5_125036115_125036346 | 0.69 |
ENSG00000222107 |
. |
349406 |
0.01 |
chr15_86164203_86164426 | 0.69 |
RP11-815J21.3 |
|
6606 |
0.15 |
chr9_113342240_113342458 | 0.69 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
189 |
0.96 |
chr9_97818122_97818533 | 0.68 |
ENSG00000207563 |
. |
29163 |
0.12 |
chr8_37005282_37005466 | 0.68 |
KCNU1 |
potassium channel, subfamily U, member 1 |
218951 |
0.02 |
chr4_54063057_54063462 | 0.68 |
ENSG00000207385 |
. |
68475 |
0.13 |
chr4_174449451_174449699 | 0.67 |
HAND2-AS1 |
HAND2 antisense RNA 1 (head to head) |
176 |
0.94 |
chr15_96865843_96865994 | 0.67 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
44 |
0.97 |
chr15_57510230_57510387 | 0.67 |
TCF12 |
transcription factor 12 |
1320 |
0.57 |
chr7_83825754_83825970 | 0.67 |
SEMA3A |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
1101 |
0.69 |
chr1_45985897_45986048 | 0.67 |
PRDX1 |
peroxiredoxin 1 |
1554 |
0.3 |
chr17_79316804_79317024 | 0.66 |
TMEM105 |
transmembrane protein 105 |
12440 |
0.13 |
chr7_135608723_135608945 | 0.66 |
AC015987.1 |
|
2369 |
0.21 |
chr4_141217669_141218059 | 0.66 |
ENSG00000252300 |
. |
21598 |
0.19 |
chr4_113474121_113474399 | 0.66 |
NEUROG2 |
neurogenin 2 |
36932 |
0.12 |
chr8_54793517_54794385 | 0.65 |
RGS20 |
regulator of G-protein signaling 20 |
497 |
0.79 |
chr5_169407172_169407407 | 0.65 |
FAM196B |
family with sequence similarity 196, member B |
455 |
0.87 |
chr1_45082713_45082906 | 0.65 |
RNF220 |
ring finger protein 220 |
9189 |
0.17 |
chr6_149745168_149745416 | 0.65 |
SUMO4 |
small ubiquitin-like modifier 4 |
23797 |
0.15 |
chr13_33778604_33778877 | 0.64 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
1403 |
0.49 |
chr5_91378122_91378273 | 0.64 |
ENSG00000264489 |
. |
363547 |
0.01 |
chr14_52707563_52708006 | 0.63 |
PTGDR |
prostaglandin D2 receptor (DP) |
26647 |
0.22 |
chr11_111888432_111888583 | 0.63 |
RP11-708L7.6 |
|
2476 |
0.17 |
chr5_169406633_169406826 | 0.63 |
FAM196B |
family with sequence similarity 196, member B |
1015 |
0.64 |
chr13_114616852_114617003 | 0.63 |
GAS6 |
growth arrest-specific 6 |
49881 |
0.16 |
chr1_172110530_172111247 | 0.63 |
ENSG00000207949 |
. |
2841 |
0.22 |
chr12_88811528_88811679 | 0.63 |
ENSG00000199245 |
. |
12616 |
0.3 |
chr9_112793978_112794147 | 0.63 |
AKAP2 |
A kinase (PRKA) anchor protein 2 |
16816 |
0.27 |
chr3_98680793_98681216 | 0.63 |
ENSG00000207331 |
. |
53701 |
0.13 |
chr11_122045276_122045427 | 0.63 |
ENSG00000207994 |
. |
22335 |
0.16 |
chr6_26555865_26556016 | 0.63 |
HMGN4 |
high mobility group nucleosomal binding domain 4 |
17307 |
0.14 |
chr1_200709373_200709640 | 0.62 |
CAMSAP2 |
calmodulin regulated spectrin-associated protein family, member 2 |
599 |
0.81 |
chr4_81191052_81191243 | 0.62 |
FGF5 |
fibroblast growth factor 5 |
3354 |
0.31 |
chr12_81102183_81102935 | 0.62 |
MYF6 |
myogenic factor 6 (herculin) |
1282 |
0.49 |
chr4_134069309_134069654 | 0.62 |
PCDH10 |
protocadherin 10 |
989 |
0.73 |
chr18_31802356_31802659 | 0.62 |
NOL4 |
nucleolar protein 4 |
225 |
0.71 |
chr5_121411439_121411590 | 0.62 |
LOX |
lysyl oxidase |
2466 |
0.34 |
chr21_17796099_17796330 | 0.62 |
ENSG00000207638 |
. |
115195 |
0.06 |
chr15_71184312_71185443 | 0.62 |
LRRC49 |
leucine rich repeat containing 49 |
88 |
0.55 |
chr13_44939064_44939222 | 0.62 |
SERP2 |
stress-associated endoplasmic reticulum protein family member 2 |
8835 |
0.28 |
chr13_33858654_33859881 | 0.62 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
625 |
0.76 |
chr21_47520199_47520351 | 0.61 |
COL6A2 |
collagen, type VI, alpha 2 |
1564 |
0.29 |
chr19_17355272_17355498 | 0.61 |
NR2F6 |
nuclear receptor subfamily 2, group F, member 6 |
72 |
0.93 |
chr4_170081571_170081722 | 0.61 |
RP11-327O17.2 |
|
41299 |
0.18 |
chr4_55095410_55095561 | 0.61 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
25 |
0.99 |
chr11_94528311_94528492 | 0.61 |
AMOTL1 |
angiomotin like 1 |
26864 |
0.2 |
chr8_25238063_25238277 | 0.61 |
GNRH1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
43577 |
0.16 |
chr8_79468522_79468695 | 0.61 |
PKIA |
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
34858 |
0.19 |
chr2_172388137_172388412 | 0.61 |
CYBRD1 |
cytochrome b reductase 1 |
8685 |
0.25 |
chr12_125678625_125678776 | 0.61 |
AACS |
acetoacetyl-CoA synthetase |
65608 |
0.13 |
chr3_74662600_74662758 | 0.61 |
ENSG00000263689 |
. |
78657 |
0.11 |
chr6_76059036_76059425 | 0.61 |
RP11-415D17.3 |
|
7700 |
0.18 |
chr20_9051097_9051248 | 0.61 |
PLCB4 |
phospholipase C, beta 4 |
1424 |
0.48 |
chr18_53665373_53665862 | 0.60 |
ENSG00000201816 |
. |
81208 |
0.12 |
chr6_106701336_106701487 | 0.60 |
ENSG00000244710 |
. |
30175 |
0.17 |
chr20_40154301_40154452 | 0.60 |
CHD6 |
chromodomain helicase DNA binding protein 6 |
26419 |
0.23 |
chr1_235665786_235665937 | 0.60 |
B3GALNT2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
1861 |
0.43 |
chr16_69959056_69959289 | 0.60 |
WWP2 |
WW domain containing E3 ubiquitin protein ligase 2 |
279 |
0.89 |
chr1_95388573_95389173 | 0.60 |
CNN3 |
calponin 3, acidic |
2464 |
0.27 |
chr9_16653585_16653783 | 0.59 |
RP11-62F24.1 |
|
28010 |
0.21 |
chr4_151504224_151504433 | 0.59 |
MAB21L2 |
mab-21-like 2 (C. elegans) |
1251 |
0.5 |
chr4_41615256_41615763 | 0.59 |
LIMCH1 |
LIM and calponin homology domains 1 |
16 |
0.99 |
chr2_66659997_66660626 | 0.59 |
MEIS1-AS3 |
MEIS1 antisense RNA 3 |
291 |
0.87 |
chr11_35035790_35035960 | 0.59 |
PDHX |
pyruvate dehydrogenase complex, component X |
36544 |
0.17 |
chr10_49812568_49813319 | 0.59 |
ARHGAP22 |
Rho GTPase activating protein 22 |
54 |
0.98 |
chr1_216018877_216019050 | 0.59 |
RP5-1111A8.3 |
|
40961 |
0.22 |
chr5_98107570_98107721 | 0.59 |
RGMB-AS1 |
RGMB antisense RNA 1 |
837 |
0.59 |
chr4_87517094_87517245 | 0.58 |
PTPN13 |
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
323 |
0.88 |
chr6_121760674_121760877 | 0.58 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
3937 |
0.22 |
chr3_25470006_25470271 | 0.58 |
RARB |
retinoic acid receptor, beta |
336 |
0.93 |
chr12_78684139_78684326 | 0.58 |
NAV3 |
neuron navigator 3 |
91376 |
0.1 |
chr11_122236647_122236798 | 0.58 |
RP11-716H6.2 |
|
70824 |
0.1 |
chr14_27066761_27066914 | 0.58 |
NOVA1 |
neuro-oncological ventral antigen 1 |
123 |
0.91 |
chr6_121760422_121760623 | 0.58 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
3684 |
0.22 |
chr5_138774627_138774795 | 0.58 |
DNAJC18 |
DnaJ (Hsp40) homolog, subfamily C, member 18 |
504 |
0.67 |
chr11_35546514_35546852 | 0.58 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
468 |
0.87 |
chr15_86292668_86292859 | 0.57 |
RP11-158M2.3 |
|
749 |
0.49 |
chr4_24107639_24107790 | 0.57 |
PPARGC1A |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
216014 |
0.02 |
chr9_14096707_14097036 | 0.57 |
NFIB |
nuclear factor I/B |
83920 |
0.11 |
chr6_56573707_56573932 | 0.57 |
DST |
dystonin |
66025 |
0.13 |
chr7_100464814_100466140 | 0.57 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr1_200216675_200216826 | 0.57 |
ENSG00000221403 |
. |
102788 |
0.07 |
chr5_89784629_89784780 | 0.57 |
POLR3G |
polymerase (RNA) III (DNA directed) polypeptide G (32kD) |
13992 |
0.17 |
chr16_65152808_65153250 | 0.56 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
2804 |
0.44 |
chr10_62332469_62332822 | 0.56 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
224 |
0.97 |
chr7_42275735_42276044 | 0.56 |
GLI3 |
GLI family zinc finger 3 |
723 |
0.82 |
chr16_53699303_53699485 | 0.56 |
RPGRIP1L |
RPGRIP1-like |
38328 |
0.17 |
chr1_57042188_57042339 | 0.56 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
2978 |
0.37 |
chr12_96183483_96184147 | 0.56 |
NTN4 |
netrin 4 |
89 |
0.96 |
chr7_93552513_93552820 | 0.56 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1655 |
0.33 |
chr16_65105770_65105991 | 0.56 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
236 |
0.97 |
chr12_23124540_23124771 | 0.56 |
ETNK1 |
ethanolamine kinase 1 |
346364 |
0.01 |
chr7_73308737_73308955 | 0.56 |
WBSCR28 |
Williams-Beuren syndrome chromosome region 28 |
33357 |
0.14 |
chr7_80547175_80548098 | 0.56 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
863 |
0.76 |
chr3_73673648_73674178 | 0.56 |
PDZRN3 |
PDZ domain containing ring finger 3 |
78 |
0.96 |
chr13_73438368_73438629 | 0.56 |
ENSG00000220981 |
. |
13272 |
0.19 |
chr4_138451326_138451477 | 0.56 |
PCDH18 |
protocadherin 18 |
2164 |
0.49 |
chr1_170639404_170639633 | 0.56 |
PRRX1 |
paired related homeobox 1 |
6440 |
0.31 |
chr12_115135696_115136278 | 0.56 |
TBX3 |
T-box 3 |
14018 |
0.21 |
chr4_183066487_183066672 | 0.55 |
AC108142.1 |
|
177 |
0.77 |
chr4_79971595_79971808 | 0.55 |
LINC01088 |
long intergenic non-protein coding RNA 1088 |
34692 |
0.21 |
chr17_1901509_1901713 | 0.55 |
CTD-2545H1.2 |
|
2703 |
0.15 |
chr3_36422437_36422689 | 0.55 |
STAC |
SH3 and cysteine rich domain |
498 |
0.89 |
chr1_116920744_116920998 | 0.55 |
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
4162 |
0.19 |
chrX_16143832_16144312 | 0.55 |
GRPR |
gastrin-releasing peptide receptor |
2393 |
0.32 |
chr8_119120675_119121215 | 0.55 |
EXT1 |
exostosin glycosyltransferase 1 |
1708 |
0.54 |
chr8_77596046_77596230 | 0.55 |
ZFHX4 |
zinc finger homeobox 4 |
122 |
0.9 |
chr2_219906038_219906221 | 0.55 |
CCDC108 |
coiled-coil domain containing 108 |
97 |
0.94 |
chr5_71453247_71453481 | 0.55 |
ENSG00000264099 |
. |
11930 |
0.23 |
chr3_64211255_64211434 | 0.54 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
213 |
0.95 |
chrX_47175743_47175914 | 0.54 |
ENSG00000266158 |
. |
35366 |
0.1 |
chr22_25348691_25349626 | 0.54 |
KIAA1671 |
KIAA1671 |
461 |
0.83 |
chrX_65896531_65896682 | 0.54 |
ENSG00000222667 |
. |
400 |
0.91 |
chr10_112411260_112411724 | 0.54 |
RBM20 |
RNA binding motif protein 20 |
7337 |
0.16 |
chr9_14096297_14096607 | 0.54 |
NFIB |
nuclear factor I/B |
84339 |
0.11 |
chr8_49831970_49832121 | 0.54 |
SNAI2 |
snail family zinc finger 2 |
1943 |
0.49 |
chr7_15725092_15725754 | 0.54 |
MEOX2 |
mesenchyme homeobox 2 |
1014 |
0.63 |
chr18_49866404_49866595 | 0.54 |
DCC |
deleted in colorectal carcinoma |
43 |
0.99 |
chr15_72072657_72072831 | 0.54 |
CTD-2524L6.3 |
|
37993 |
0.17 |
chr4_146653475_146653734 | 0.53 |
ZNF827 |
zinc finger protein 827 |
32603 |
0.17 |
chr17_879023_879210 | 0.53 |
NXN |
nucleoredoxin |
3894 |
0.17 |
chr6_128813060_128813280 | 0.53 |
RP1-86D1.5 |
|
8502 |
0.17 |
chr4_77508066_77508217 | 0.53 |
ENSG00000265314 |
. |
11437 |
0.17 |
chr6_127022954_127023417 | 0.53 |
ENSG00000201613 |
. |
111646 |
0.07 |
chr1_79472185_79472383 | 0.53 |
ELTD1 |
EGF, latrophilin and seven transmembrane domain containing 1 |
119 |
0.98 |
chr3_114168204_114168554 | 0.53 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
5151 |
0.29 |
chr3_70910934_70911123 | 0.53 |
ENSG00000221382 |
. |
16915 |
0.26 |
chr12_115120620_115120912 | 0.53 |
TBX3 |
T-box 3 |
629 |
0.77 |
chr12_88972313_88972545 | 0.53 |
KITLG |
KIT ligand |
1809 |
0.39 |
chr16_4424352_4424847 | 0.53 |
VASN |
vasorin |
2750 |
0.17 |
chr21_17568903_17569232 | 0.52 |
ENSG00000201025 |
. |
88022 |
0.1 |
chr8_29970332_29970518 | 0.52 |
LEPROTL1 |
leptin receptor overlapping transcript-like 1 |
10969 |
0.15 |
chr7_27681378_27681771 | 0.52 |
HIBADH |
3-hydroxyisobutyrate dehydrogenase |
5801 |
0.29 |
chr12_49762378_49762529 | 0.52 |
SPATS2 |
spermatogenesis associated, serine-rich 2 |
1123 |
0.4 |
chr1_98515040_98515403 | 0.52 |
ENSG00000225206 |
. |
3494 |
0.38 |
chr7_19152817_19152968 | 0.52 |
AC003986.6 |
|
795 |
0.57 |
chr4_95896202_95896359 | 0.52 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
20667 |
0.3 |
chr13_27757022_27757206 | 0.52 |
USP12-AS2 |
USP12 antisense RNA 2 (head to head) |
10718 |
0.14 |
chr8_16689434_16690090 | 0.52 |
ENSG00000264092 |
. |
31243 |
0.24 |
chr8_29249786_29249937 | 0.52 |
RP4-676L2.1 |
|
39174 |
0.14 |
chr17_38440207_38440497 | 0.52 |
CDC6 |
cell division cycle 6 |
3533 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 1.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.3 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.6 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.6 | GO:0003078 | obsolete regulation of natriuresis(GO:0003078) |
0.2 | 0.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.2 | 1.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:0072143 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.1 | 0.4 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.5 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.6 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 1.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.3 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.2 | GO:0016199 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.1 | 0.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.5 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.5 | GO:0060840 | artery morphogenesis(GO:0048844) artery development(GO:0060840) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 1.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.1 | 0.3 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:1900115 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0045920 | negative regulation of exocytosis(GO:0045920) |
0.0 | 0.1 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 6.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.5 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.6 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.0 | GO:0072191 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter development(GO:0072189) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.0 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.8 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.0 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.1 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) |
0.0 | 0.1 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0044254 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.0 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0031065 | regulation of histone deacetylation(GO:0031063) positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.4 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0006533 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.2 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.3 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:1901984 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.1 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.2 | GO:0098764 | meiotic prophase I(GO:0007128) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.3 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.3 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.0 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.0 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.0 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.1 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0031935 | regulation of chromatin silencing(GO:0031935) negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.0 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0048679 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0008306 | associative learning(GO:0008306) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.4 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.5 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0045217 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.0 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.9 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.4 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 2.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.0 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 1.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 1.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.5 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 1.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 4.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.3 | GO:0043292 | myofibril(GO:0030016) contractile fiber(GO:0043292) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.3 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.0 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 1.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 1.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.9 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 1.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.8 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 1.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.6 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 2.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0051637 | obsolete Gram-positive bacterial cell surface binding(GO:0051637) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 7.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 1.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 3.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 2.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 1.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.3 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |